Navigation Links
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
Date:7/14/2009

In addition to EZN/SPC2968 and EZN/SPC3042 Enzon has now received all the remaining six novel cancer drug candidates from Santaris Pharma and Enzon has announced the targets for four of these compounds: Her3, beta catenin, PIK3CA and the androgen receptor.

Pipeline Summary

In H1 2009 Santaris Pharma continued the progress for both the drug discovery programs and the drug development pipeline. At the end of June Santaris Pharma had four drugs in clinical development:

    - SPC3649, an LNA-antimiR(R) against microRNA-122, being
      developed for the treatment of HCV infections

    - EZN/SPC2968, a HIF-1alpha inhibitor, being developed for the
      treatment of various solid tumors

    - SPC2996, a Bcl-2 inhibitor, being developed for the
      treatment of cancer. Santaris Pharma has initiated the process of
      divesting this candidate

    - EZN3042, an LNA-based Survivin inhibitor, being developed
      for the treatment of various solid tumors

In addition to the four clinical development stage compounds Santaris Pharma and its partners have several other compounds in the discovery, research and preclinical stages, including the new apoB inhibitor, SPC4955 which now enters preclinical development and the PCSK9 lead candidates which are ready for pharmacological studies.

See Santaris Pharma's pipeline through this link: http://www.santaris.com/Library/documents/Santaris_Pharma_Interim_Report_1_Ja nuary_to_30_June_2009.pdf

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Research

During H1 2009 Santaris Pharma and/or partners have published six scientific articles and more have been submitted
'/>"/>

SOURCE Santaris Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
2. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
3. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... , Jan. 14, 2014 The largest international ... medicinal plants and therapeutic derivatives thereof has endorsed ... and researchers about the challenges of adulterated herb ... ) The Society for Medicinal ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, provider of ... ) and sales and operations planning ( S&OP ) service, ... Biomanufacturing Summit , which will be held at the Hilton ... conference, join Kinaxis customer Elisabeth Kaszas , Director of ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... , , ... the world,s preeminent cord blood banks, today announced that Shannon Miller ... endorsement partnership agreement and will appear in a series of advertising and ... http://www.newscom.com/cgi-bin/prnh/20090528/NY23885LOGO ) , , Considered "The ...
... NATICK, Mass., Aug. 24 Boston Scientific Corporation (NYSE: ... from the landmark MADIT-CRT trial on Tuesday, September 1, at 8:00 ... , The call will be hosted by Ray Elliott, ... Group President, Cardiac Rhythm Management; and Arthur Moss, M.D., Professor of ...
... BOZEN, Italy, August 24 ... of its recent partnership announcement with McKesson, it,has ... 13 North American,customers in just a few days ... hospital policies prevent them from publicly,commenting on industry ...
Cached Biology Technology:7-Time Olympic Medalist Shannon Miller Endorses StemCyte 2Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 3Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 4
(Date:4/23/2014)... of Public Health-Bloomington has bolstered the link between red ... association between heme iron, found only in meat, and ... that heme iron consumption increased the risk for coronary ... found between nonheme iron, which is in plant and ... study was published online ahead of print in the ...
(Date:4/23/2014)... Toronto Scarborough research shows that male black widow spiders ... a rare example of mate preference by male spiders. ... Emily MacLeod and Maydianne Andrade, a professor in UTSC,s ... studies and the wild that males overwhelmingly chose to ... black widows can tell whether a potential mate is ...
(Date:4/23/2014)... of an accurate group decision increases with the abundance ... collective faces a variety of factors as often ... report that smaller groups actually tend to make more ... on only certain pieces of information. , The findings ... collective intelligence, or the "wisdom of crowds," wherein individual ...
Breaking Biology News(10 mins):Study: Iron consumption can increase risk for heart disease 2Picky male black widow spiders prefer well-fed virgins 2Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
... A multidisciplinary clinical practice guideline, "Tonsillectomy in Children" will ... and Neck Surgery (watch for a new cover ... new guideline provides evidence-based recommendations on the pre-, intra-, ... to 18 years under consideration for tonsillectomy. Additionally, this ...
... dominant natural process of new species formation and trigger ... in the journal PLoS ONE . The ... to 375 million years ago suggests that the planet,s ... meet a similar fate. Although Earth has experienced ...
... provide a significant source of revenue in southern ... during the holiday buying season. The most popular ... for its fragrance and consumer-friendly traits such as ... natural Christmas tree shape. Frasers, indigenous to isolated ...
Cached Biology News:Tonsillectomy in children 2What triggers mass extinctions? Study shows how invasive species stop new life 2What triggers mass extinctions? Study shows how invasive species stop new life 3April grafting optimal for Fraser fir 2
... Dyad thermal cycler is a flexible ... chassis accommodates a variety of interchangeable ... hold different types and numbers of ... with point-and-click navigation. Peltier heat pumps, ...
For demonstration of Helicobacter pylori...
... Disruption of the mitochondrial transmembrane ... earliest intracellular events that occur ... MitoLight Apoptosis Detection Kit utilizes ... MitoLight, as a mitochondrial activity ...
The PDS-1000 He Hepta system includes the PDS-1000 He biolistic system and the Hepta adaptor....
Biology Products: